Latest News & Features
Americas
Scott Gottlieb, commissioner of the Food and Drug Administration,, yesterday announced another set of guidelines aimed at facilitating the entry of generic drugs to the market and preventing “gaming” of the approval system. 3 October 2018
Asia
A recent case in India reveals the various ways in which pharmaceutical patents can be challenged, as Neeti Wilson, Arpita Kulshreshtha and Gitika Suri of Anand and Anand report. 2 October 2018
Americas
Dykema has strengthened its Minneapolis, Minnesota office with the addition of two lawyers from Moore & Hansen as senior counsel. 2 October 2018
Americas
The US International Trade Commission yesterday announced that it will launch a patent infringement investigation into medical device maker Fisher & Paykel Healthcare, based in New Zealand. 2 October 2018
Big Pharma
Crowell & Moring has welcomed Gunther Meyer, who previously led the Brussels IP group at Eversheds Sutherland, as a senior counsel in the firm’s IP group. 2 October 2018
Europe
BIO-Europe heads to Scandinavia for the first time, as Copenhagen plays host in November. LSIPR finds out more. 2 October 2018
Asia
Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China. 1 October 2018
Americas
Teva has once again taken Eli Lilly to court over a migraine drug, just hours after Eli Lilly’s gained Food and Drug Administration approval to market Emgality. 1 October 2018
Americas
US-based Alexion Pharmaceuticals has announced its plan to acquire Syntimmune, a clinical-stage biotechnology company. 1 October 2018
article
The issue of inefficiencies in the life sciences IP market is a hot topic to be discussed at the Life Science IP Forum in London in November, as LSIPR finds out. 1 October 2018